Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. (Q53223435)
Jump to navigation
Jump to search
scientific article published in January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. |
scientific article published in January 2008 |
Statements
Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. (English)
1 reference
Devendra K Hiwase
1 reference
Smita Hiwase
1 reference
Geraldine Bollard
1 reference
Anthony P Schwarer
1 reference
1 January 2008
1 reference
14
1 reference
1
1 reference
116-124
1 reference
Identifiers
1 reference